Related Experiment Video

Updated: Aug 13, 2026

Derivation of Thymic Lymphoma T-cell Lines from Atm-/- and p53-/- Mice
17:59

Derivation of Thymic Lymphoma T-cell Lines from Atm-/- and p53-/- Mice

Published on: April 3, 2011

12.7K

[Hodgkin lymphoma]

Momoko Nishikori1

  • 1Department of Hematology/Oncology, Kyoto University, Graduate School of Medicine.

[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|June 7, 2019
PubMed

Insights

New Hodgkin lymphoma treatments targeting CD30 and immune pathways show remarkable efficacy. These advancements improve survival for patients resistant to chemotherapy and deepen understanding of the disease.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Hodgkin lymphoma features CD30 overexpression and NF-κB pathway activation in malignant Hodgkin/Reed-Sternberg (H/RS) cells.
  • H/RS cells reside within an inflammatory and immunoinhibitory microenvironment, prompting research into modulating this milieu.
  • Targeting CD30 and its signaling pathways, as well as the tumor immune microenvironment, are key therapeutic strategies.

Purpose of the Study:

  • To review recent advancements in Hodgkin lymphoma treatment targeting CD30 and immune pathways.
  • To highlight the efficacy of novel therapeutic agents in improving patient survival.
  • To discuss the implications of these treatments for understanding Hodgkin lymphoma pathogenesis.

Main Methods:

  • Review of recent clinical data and research on Hodgkin lymphoma therapeutics.
  • Analysis of the molecular mechanisms underlying CD30 signaling and immune checkpoint inhibition.
  • Examination of the impact of new agents on patient outcomes and disease biology.

Main Results:

  • CD30 antibody-drug conjugates and immune checkpoint inhibitors have demonstrated significant efficacy.
  • These novel treatments have improved survival rates for patients refractory to conventional chemotherapy.
  • New agents have enhanced the understanding of PD-1 and JAK/STAT pathway involvement in Hodgkin lymphoma.

Conclusions:

  • Targeted therapies like CD30 ADCs and ICIs represent major progress in Hodgkin lymphoma treatment.
  • These therapies offer new hope for patients with refractory disease.
  • Further research into these pathways will continue to refine treatment strategies for Hodgkin lymphoma.

Keywords:
CD30Hodgkin lymphomaHodgkin/Reed-Sternberg cellsPD-1

More Related Videos

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma08:53

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Published on: June 10, 2017

10.4K
Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.6K

Related Concept Videos

Lymphoid Cells and Tissues01:18

Lymphoid Cells and Tissues

Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Primary Lymphoid Organs01:16

Primary Lymphoid Organs

Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Secondary Lymphoid Organs01:15

Secondary Lymphoid Organs

Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...